HSCT
Hematologic disease
Rhinosinusitis
With GVHD
Myeloablative:
12 (75%)
Non-myeloablative:
4 (25%)
CLM
: 5 (31%)
ALM
: 5 (31%)
MM
: 2 (12.5%)
CLL
: 1 (6%)
AA
: 1 (6%)
MDS
: 2 (12.5%)
1 – 2 RS:
9 (56.2%)
3 ou>RS:
7 (43.7%)
Without GVHD
Myeloablative:
5 (62.5%)
Non-myeloablative
: 3 (37.5%)
ALL:
2 (25%)
MM
: 1 (12.5%)
SCA:
1 (12.5%)
AA:
2 (25%)
MDS
: 2 (25%)
1 – 2 RS:
6 (75%)
3 ou>RS:
2 (25%)
Captions:
HSCT: Hematopoietic Stem Cell Transplant; CML: Chronic Myeloid Leukemia; AML: Acute Myeloid Leukemia; MM: Multiple Myeloma; CLL: Chronic Lymphocytic Leukemia; AA: Aplastic Anemia; MDS: Myelodysplastic Syndrome; ALL: Acute Lymphoblastic Leukemia; SCA: Sickle Cell Anemia; RS: Rhinosinusitis
Table 1:
Groups of transplanted hematopoietic stem cells in patients with rhinosinusitis.
